EUVIMEDEUVIMED entdecken
Open Access

Deciphering linezolid-induced hematologic toxicity: Targeting TOP2A and TOP2B via its primary metabolite PNU142586

Vo Thuy Anh Thu iD, Nguyen Quynh Nhu iD, Nguyen Thi Van Anh, So-An Lim iD, Hyeon-Jeong Seong iD, Jony Md Rasheduzzaman iD, Uijin Kim, Hyun-Soo Cho iD, Soedarsono Soedarsono iD, Jae-Gook Shin iD, Yong-Soon Cho iD

Science Advances · 2025

DOI: 10.1126/sciadv.adt5833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Vo Thuy Anh Thu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Korea. Hauptthemen laut MEDLINE: Linezolid, DNA Topoisomerases, Type II, Hematologic Diseases, Topoisomerase II Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Linezolid, an oxazolidinone antibiotic, is widely used to treat multidrug-resistant tuberculosis and drug-resistant Gram-positive infections. However, prolonged use is associated with severe hematologic toxicity, the underlying mechanisms of which remain incompletely understood, particularly regarding the role of linezolid metabolites. Our clinical study indicates that elevated exposure to PNU142586, a primary metabolite of linezolid, is associated with an increased risk of linezolid-induced toxicity, even in the absence of renal impairment. To elucidate its mechanism, we identify DNA topoisomerase 2-α (TOP2A) and DNA topoisomerase 2-β (TOP2B) as primary targets of PNU142586 at molecular, cellular, and in vivo levels. PNU142586 disrupts replication and transcription by impeding DNA binding to TOP2A and TOP2B with a favorable conformation for cleavage and by inhibiting adenosine 5′-triphosphate hydrolysis, ultimately leading to antiproliferative and cytotoxic effects, including mitochondrial dysfunction. The present study thus provides mechanistic insight into linezolid-induced hematologic toxicity and offers a foundation for safer antibiotic development and improved clinical monitoring through biomarker identification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinezolidDNA Topoisomerases, Type IIHematologic DiseasesTopoisomerase II InhibitorsHumansAnimalsMiceMaleFemaleAnti-Bacterial AgentsPoly-ADP-Ribose Binding Proteins

Substanzen

LinezolidDNA Topoisomerases, Type IITOP2A protein, humanTOP2B protein, humanAnti-Bacterial AgentsTopoisomerase II InhibitorsPoly-ADP-Ribose Binding Proteins

Autor:innen und Institutionen

  • Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Korea.
  • Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Korea.
  • Department of Systems Biology, Yonsei University, Seoul 03722, Republic of Korea.
  • Institute for Bio-medical Convergence Science and Technology, Yonsei University, Seoul 03722, Republic of Korea.
  • Sub-pulmonology Department of Internal Medicine, Faculty of Medicine, Hang Tuah University, Surabaya, Indonesia.
  • Dr. Soetomo Academic General Hospital, Surabaya, Indonesia.

ORCID-Profile: Vo Thuy Anh Thu, Nguyen Quynh Nhu, So-An Lim, Hyeon-Jeong Seong, Jony Md Rasheduzzaman, Hyun-Soo Cho, Soedarsono Soedarsono, Jae-Gook Shin, Yong-Soon Cho

Zitieren

APA

Thu, V. T. A., Nhu, N. Q., Anh, N. T. V., Lim, S. A., Seong, H. J., Md Rasheduzzaman, J., Kim, U., Cho, H. S., Soedarsono, S., Shin, J. G., & Cho, Y. S. (2025). Deciphering linezolid-induced hematologic toxicity: Targeting TOP2A and TOP2B via its primary metabolite PNU142586. Science Advances. https://doi.org/10.1126/sciadv.adt5833

Vancouver

Thu VTA, Nhu NQ, Anh NTV, Lim SA, Seong HJ, Md Rasheduzzaman J, et al. Deciphering linezolid-induced hematologic toxicity: Targeting TOP2A and TOP2B via its primary metabolite PNU142586. Science Advances. 2025. doi:10.1126/sciadv.adt5833

BibTeX
@article{Thu2025,
  author = {Thu, Vo Thuy Anh and Nhu, Nguyen Quynh and Anh, Nguyen Thi Van and Lim, So-An and Seong, Hyeon-Jeong and Md Rasheduzzaman, Jony and Kim, Uijin and Cho, Hyun-Soo and Soedarsono, Soedarsono and Shin, Jae-Gook and Cho, Yong-Soon},
  title = {Deciphering linezolid-induced hematologic toxicity: Targeting TOP2A and TOP2B via its primary metabolite PNU142586},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adt5833}
}
Kostenlos starten →